Form 4: TransMedics Group Director, Merilee Raines, Acquires Shares and Stock Options

Director Merilee Raines acquired 732 shares of common stock and stock options for 1,154 shares in TransMedics Group, Inc.

Summary

• On May 23, 2024, Merilee Raines, a director of TransMedics Group, Inc., acquired 732 shares of common stock in the form of restricted stock units (RSUs) at a price of $0.00.
• Each RSU represents a contingent right to receive one share of TransMedics Group's common stock.
• Following this transaction, Raines directly owns 1,925 shares of common stock.
• Raines also acquired stock options for 1,154 shares of common stock with an exercise price of $137.53.
• These options vest fully on the earlier of May 23, 2025, or the date of the 2025 annual meeting of stockholders, contingent upon continued service.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions. The acquisition of shares and options could be seen as a positive signal, but it's not a major event.

Positives

• The acquisition of shares and stock options by a director may signal confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely monitored by investors to gauge sentiment and potential future performance.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment.

Key Dates